Kedudukan dalam Saham
#37893
Nextgen Biomed Ltd focuses on developing external dermatological treatments for... Nextgen Biomed Ltd focuses on developing external dermatological treatments for psoriasis. The company, which was established in 1990, originally operated under the name Sela Group.Com Ltd. before rebranding as Nextgen Biomed Ltd in February 2010. Its operations are headquartered in Tel Aviv, Israel.
Harga Saham
$0.14896012
Disegerakkan terakhir: 2026-02-16
Perubahan (1 hari)
-2.89%
Perubahan (1 tahun)
-19.65%
Perdagangan Nextgen Biomed Ltd (NXGN)
Harga NXGN dengan permodalan pasaran b
Modal pasaran bagi Nextgen Biomed Ltd(NXGN)
Modal Pasaran: $1.37M
Sehingga August 2026, Nextgen Biomed Ltd mempunyai modal pasaran sebanyak $1.37M. Ini menjadikan Nextgen Biomed Ltd syarikat ke-37893rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Nextgen Biomed Ltd dari 2002 hingga 2026
NXGN berbanding dengan 5 teratas yang paling popular stocks
| Harga NXGN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+398,065,343.54%
|
|
|
|
|
$4.490T
|
+327,836,516.29%
|
|
|
|
|
$4.162T
|
+303,916,003.09%
|
|
|
|
|
$3.676T
|
+268,426,236.67%
|
|
|
|
|
$2.833T
|
+206,853,115.18%
|
